Millipore Sigma Vibrant Logo

MAB8910 Anti-Measles Blend Antibody, matrix protein, clones CV8, CV9

View Products on Sigmaaldrich.com
MAB8910
100 µL  
Prix en cours de récupération
Le prix n'a pas pu être récupéré
La quantité minimale doit être un multiple de
Maximum Quantity is
À la validation de la commande Plus d'informations
Vous avez sauvegardé ()
 
Demander le prix
Disponibilité limitée
Disponibilité limitée
En stock 
Interrompu(e)
Disponible en quantités limitées
Disponibilité à confirmer
    Pour le restant : Nous vous tiendrons informé
      Pour le restant : Nous vous tiendrons informé
      Nous vous tiendrons informé
      Contacter le Service Clients
      Contact Customer Service

      Offres spéciales

       

      Contacter le Service Clients

      Aperçu

      Replacement Information

      Offres spéciales

      Tableau de caractéristiques principal

      Species ReactivityKey ApplicationsHostFormatAntibody Type
      HIFMPurifiedMonoclonal Antibody
      Description
      Catalogue NumberMAB8910
      Brand Family Chemicon®
      Trade Name
      • Chemicon
      DescriptionAnti-Measles Blend Antibody, matrix protein, clones CV8, CV9
      Alternate Names
      • Rubeola
      References
      Product Information
      FormatPurified
      PresentationIn 0.02M PB with 0.25M NaCl containing 0.1% sodium azide, pH 7.6.
      Quality LevelMQ300
      Applications
      ApplicationDetect Measles Blend using this Anti-Measles Blend Antibody, matrix protein, clones CV8, CV9 validated for use in IF.
      Key Applications
      • Immunofluorescence
      Application NotesIndirect Immunofluorescence

      Final working dilutions must be determined by end user.
      Biological Information
      Epitopematrix protein
      CloneCV8, CV9
      ConcentrationPlease refer to the Certificate of Analysis for the lot-specific concentration.
      HostMouse
      SpecificityRecognizes the measles matrix protein by indirect immunofluorescence.
      IsotypeIgG
      Species Reactivity
      • Human
      Antibody TypeMonoclonal Antibody
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Usage Statement
      • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
      Storage and Shipping Information
      Storage ConditionsMaintain at 2-8°C in aliquots for up to 12 months.
      Packaging Information
      Material Size100 µL
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Référence GTIN
      MAB8910 04053252610363

      Documentation

      Anti-Measles Blend Antibody, matrix protein, clones CV8, CV9 FDS

      Titre

      Fiche de données de sécurité des matériaux (FDS) 

      Anti-Measles Blend Antibody, matrix protein, clones CV8, CV9 Certificats d'analyse

      TitreNuméro de lot
      MOUSE ANTI-MEASLES (MATRIX PROTEIN) MAB8910
      MOUSE ANTI-MEASLES (MATRIX PROTEIN) 3069325
      MOUSE ANTI-MEASLES (MATRIX PROTEIN) MONOCLONAL ANTIBODY - 2393906 2393906
      MOUSE ANTI-MEASLES (MATRIX PROTEIN) MONOCLONAL ANTIBODY - 2430443 2430443
      MOUSE ANTI-MEASLES (MATRIX PROTEIN) - 2564851 2564851
      MOUSE ANTI-MEASLES (MATRIX PROTEIN) - 3224207 3224207
      MOUSE ANTI-MEASLES (MATRIX PROTEIN) - 3268924 3268924
      MOUSE ANTI-MEASLES (MATRIX PROTEIN) - 3385809 3385809
      MOUSE ANTI-MEASLES (MATRIX PROTEIN) - 3546919 3546919
      MOUSE ANTI-MEASLES (MATRIX PROTEIN) -2521475 2521475

      Références bibliographiques

      Aperçu de la référence bibliographiqueNº PubMed
      Mutations in the H, F, or M Proteins Can Facilitate Resistance of Measles Virus to Neutralizing Human Anti-MV Sera.
      Kweder, H; Ainouze, M; Cosby, SL; Muller, CP; Lévy, C; Verhoeyen, E; Cosset, FL; Manet, E; Buckland, R
      Advances in virology  2014  205617  2014

      Afficher le résumé
      24648840 24648840
      Actin filaments disruption and stabilization affect measles virus maturation by different mechanisms.
      Dietzel, E; Kolesnikova, L; Maisner, A
      Virology journal  10  249  2013

      Afficher le résumé
      23914985 23914985
      Elements in the canine distemper virus M 3' UTR contribute to control of replication efficiency and virulence.
      Anderson, DE; Castan, A; Bisaillon, M; von Messling, V
      PloS one  7  e31561  2011

      Afficher le résumé
      22348107 22348107
      Electron cryotomography of measles virus reveals how matrix protein coats the ribonucleocapsid within intact virions.
      Liljeroos, L; Huiskonen, JT; Ora, A; Susi, P; Butcher, SJ
      Proceedings of the National Academy of Sciences of the United States of America  108  18085-90  2010

      Afficher le résumé
      22025713 22025713
      Canine distemper virus matrix protein influences particle infectivity, particle composition, and envelope distribution in polarized epithelial cells and modulates virulence.
      Dietzel, E; Anderson, DE; Castan, A; von Messling, V; Maisner, A
      Journal of virology  85  7162-8  2010

      Afficher le résumé
      21543493 21543493
      Measles virus M protein driven particle production does not involve the ESCRT system.
      A Salditt, S Koethe, C Pohl, H Harms, L Kolesnikova, S Becker, S Schneider-Schaulies
      The Journal of general virology  2009

      Afficher le résumé
      20130136 20130136
      Measles virus M and F proteins associate with detergent-resistant membrane fractions and promote formation of virus-like particles.
      Pohl, C; Duprex, WP; Krohne, G; Rima, BK; Schneider-Schaulies, S
      The Journal of general virology  88  1243-50  2007

      Afficher le résumé
      17374768 17374768
      Measles virus nucleocapsid transport to the plasma membrane requires stable expression and surface accumulation of the viral matrix protein.
      Nicole Runkler,Christine Pohl,Sibylle Schneider-Schaulies,Hans-Dieter Klenk,Andrea Maisner
      Cellular microbiology  9  2007

      Afficher le résumé
      17217427 17217427
      RNA interference with measles virus N, P, and L mRNAs efficiently prevents and with matrix protein mRNA enhances viral transcription.
      Reuter, T; Weissbrich, B; Schneider-Schaulies, S; Schneider-Schaulies, J
      Journal of virology  80  5951-7  2005

      Afficher le résumé
      16731933 16731933
      Full-length sequence analysis of subacute sclerosing panencephalitis (SSPE) virus, a mutant of measles virus, isolated from brain tissues of a patient shortly after onset of SSPE.
      Hak Hotta, Kenji Nihei, Yu-ichi Abe, Seiichi Kato, Da-Peng Jiang, Motoko Nagano-Fujii, Kiyonao Sada
      Microbiology and immunology  50  525-34  2005

      Afficher le résumé
      16858143 16858143

      Fiche technique

      Titre
      MOUSE ANTI-MEASLES (MATRIX PROTEIN) MONOCLONAL ANTIBODY

      Produits & Applications associés

      Alternative Packsize

      Référence Description  
      MAB8910-KC Mouse Anti-Measles (Matrix Protein), clone CV8, CV9 (1mg) KC Prix & Disponibilité

      Catégories

      Life Science Research > Antibodies and Assays > Primary Antibodies